Evidence map›Paper›PMID 41357270›Full record

ArticleHeart rhythm O22025

Preparticipation electrocardiogram screening in a Gulf Coast community: A prospective study.

Lane A McLendon, Madhuri S Mulekar, Lynn A Batten

Abstract read
In one paragraph

Article in Heart rhythm O2, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Lane A McLendonDepartment of Pediatric Cardiology, Cleveland Clinic Children's, Cleveland, Ohio.
Madhuri S MulekarDepartment of Mathematics and Statistics, University of South Alabama, Mobile, Alabama.
Lynn A BattenDivision of Pediatric Cardiology, Department of Pediatrics, University of South Alabama, Mobile, Alabama.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Sudden cardiac death in young athletes is a devastating event unparalleled in the sports community. The debate over electrocardiogram (ECG) screening of young athletes has been ongoing for many years and recommendations vary widely. Objective: We prospectively studied students in coastal Alabama to compare the detection rate of life-threatening cardiac pathology using a 12-lead ECG vs a preparticipation questionnaire. Methods: A total of 2604 students in coastal Alabama aged 5-22 years (median age, 15 years) were included between 2014 and 2019. They completed the American Heart Association (AHA) 14-point preparticipation questionnaire and underwent a 12-lead ECG. Results: Of participants answering the questionnaire, 60.2% were men, 81.4% were White, and 10.7% were Black. There were 306 (11.9%) of 2565 students who reported symptoms that would have triggered referral to a cardiologist, with the most common (88.2%) being chest pain, shortness of breath, and palpitations. Of 2604 ECGs, 86 (3.3%) were abnormal, with the most frequent findings (54.7%) being T wave inversions and pathologic Q waves. The AHA screening questionnaire had a sensitivity of 33.0% and specificity of 78.7%, while the ECG screening had 100% sensitivity and 97.0% specificity. Three students (0.1%) were found to have conditions associated with sudden cardiac arrest which were detected by ECG, although only 1 of these students reported symptoms on the questionnaire which would have prompted a referral. Conclusion: The 14-point AHA questionnaire raised suspicion for unnecessary referrals while missing 66.0% of the life-threatening pathologies detected with ECG.

Indexed as

Athlete screenCardiac arrestElectrocardiogramQuestionnaireSports physical

Identifiers

PMID41357270
PMCPMC12675059

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.